Thanks for posting this MAC, will be very useful when things get cracking.
Printable View
Below job add posted today - note highlighted new products " state of the art cancer management products". Seems a natural progression from the diagnostic tools - not sure if this has been disclosed before (surprised if it hasn't).
Ref /Job ID: 88386796438C02E7 / 5952385 Industry: Science, Technology, R&D, Biotech Company:Pacific Edge Limited Location:Australia Australia 0 - 0 Type: Full Time Advertiser: Agency Posted: 31-08-2013 Closing: 07-09-2013
Pacific Edge Limited is a Dunedin-based biomedical company specialisingin the development and commercialisation of diagnostics and prognostics for arange of cancers including bladder, colorectal and gastric. The Company hascompleted a successful international multicenter clinical trial for its bladdercancer detection test Cxbladder. The Company’s colorectal cancer prognosticgene signature has also recently successfully completed its clinical trial inEurope. Pacific Edge Limited has nowmoved to commercialise these products into global markets. As part of ourdevelopment and growth strategy Pacific Edge Limited has formed aninternational network of collaborations and alliances with research institutesand companies in Australasia, North America, Europe and Asia. The Company isnow seeking to appoint a top-level scientist who will be considered critical indeveloping and implementing the Company’s clinical program for moleculardiagnostic testing and contribute to thevision of developing state of the art cancer management products. Thesuccessful candidate will join a commercial, product-focused team in anenvironment where communication and collaboration are essential. You will beinvolved in all facets of the clinical program development including buildingline extensions to existing products, implementation of product pipelines andevaluating novel molecular diagnostics tests in a commercial laboratorysetting. Specifically applicants will have: • PhD in a relevant sciencediscipline with a minimum of 4 years post doctoral experience • Proven abilityto plan, execute and report scientific clinical studies • Experience with therunning of human clinical trials • A knowledge of or strong interest inclinical diagnostics • Ability to communicate fluently verbally and in writingto a wide variety of stakeholders, including physicians • Ability to performwell as a member of a team as well as showing leadership in areas of primaryresponsibility • Flexible can-do attitude • A willingness and aptitude to help turnscientific ideas into commercial reality. It would be advantageous forapplicants to have: • A knowledge of the regulatory environment for clinicallaboratories • Experience with bio resource collections (Bio Banks) We areoffering an exciting and challenging job with a competitive salary commensuratewith experience and skills. Pacific Edge Limited is based in Dunedin in closeproximity to the University of Otago and the successful candidate will beworking with a professional team in a great working environment.
Perhaps someone from the health sector can assist ?
At the AGM David Darling advised that PEB are presently selling in the US at a price point of $550 per test, and I’m still trying to interpret what this actually means. This is at the lower end of the 2011 capital raising guidance of $550 to $630.
A common sales and marketing strategy is to offer ‘trials’ at a lower price, once both parties are satisfied with the results, sales may continue at a normal (higher) price point, let’s say $630 per test.
Or, is this not a customary sales practice in the health sector ?
So we may also have some sort of a wholesale / retail thing going on also ?. I guess that may mean that direct sales to the US insurers may then come at a higher price point.
I'm actually very encouraged that PEB are presently "in discussion" with their first US customer, the fact that PEB are prepared to publicly declare this suggests they are confident it will indeed happen. And, being roughly three times the size of all NZ DHB’s combined, well need we say more.
I'm increasingly becoming more bullish, it seems that after years of kicking around the lab we are at the tipping point of sales exploding now.
Even just having a few LUG's under trial would represent huge sales volumes.
Don't wait too long baller... not sure how long it will be before the general public realise they are on the cusp of big sales. Hopefully a bit longer (and the price falls a bit more!) so I can top up at stupid prices too!
There was continued selling on the close Friday, this time with a 500k parcel lobbed out.
probably the same seller we have seen all week. Watch the open and close to see if they are still exiting in 50, 100, and now 500k parcels
my concern is it must be one of the larger holders (who still lobbed out after the NBR reported comments) What do they know?, but then what do I know, lol
the 60 cent capper has come down to market I suspect, but it's only conjecture on my part.
would that buyer of 333,333 the other week like to step up for another 555,555. Lucky for some.....
Two good unreliable indicators of stock market probability this morning, much more light and agricultural aircraft traffic recently and hemlines are definitely on the rise.:)